journal article·2023-07-25Open access

Echinacoside-Zinc Nanomaterial Inhibits Skin Glycation by Suppressing the Transcriptional Activation of the Receptor for Advanced Glycation End-Products

Jingxia Han, Yu Sun, Ting Wu, Xiaohui Hou, Shaoting Zheng, Haohao Zhang, Tingting Lin, Huijuan Liu, Tao Sun

ACS Nano· Volume 17· Issue 14

Abstract

High Resolution Image Download MS PowerPoint Slide Glycation is a nonenzymatically catalyzed spontaneous reaction that eventually leads to the formation of advanced glycation end-products (AGEs), which can bind to the receptor for AGEs (RAGE). The consequences are oxidative damage, an inflammatory response, and aging. In this work, we synthesized echinacoside-zinc coordination polymers (ECH-Zn) by using the coordination interaction between the catechol group of ECH and zinc ions. ECH-Zn was further wrapped with hyaluronic acid/poly (ethylenimine) (HA-PEI) to obtain spherical nanoparticle polymers of HA-PEI-coated ECH-Zn (PPZn). PPZn can enhance the uptake and utilization of ECH-Zn and also have a better antiglycation effect in the skin under the effect of promoting transdermal absorption of HA-PEI. Mechanistic studies at the cellular level showed that MDM2 can interact with STAT2 to form a transcriptional complex and thus promote RAGE transcriptional activation. In vitro and in vivo studies revealed that PPZn can decrease the expression and inhibit the interaction of the MDM2/STAT2 complex. It inhibited the function of the MDM2/STAT2 complex and suppressed the transcriptional activation of RAGE, thereby exerting antiglycation effects. In conclusion, this work provides a nanomaterial and elucidated a mechanism of anti-skin glycation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Glycation End Products research · Neurological Disease Mechanisms and Treatments · Neuroinflammation and Neurodegeneration Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, 300350, China

Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, 300457, China

Medical Plastic and Cosmetic Center, Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin Medical University Eye Hospital, Tianjin, 300384, China

Funding

Natural Science Foundation of Tianjin City · China Postdoctoral Science Foundation · Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Central Committee of the Communist Party of China

References (52)

Show source-provided references
1. 10.1016/j.foodres.2019.10884310.1016/j.foodres.2019.108843 ↗
2. 10.1155/2020/381819610.1155/2020/3818196 ↗
3. 10.1016/s1357-2725(96)00079-910.1016/s1357-2725(96)00079-9 ↗
4. Pageon H. · 2017 · 124710.1007/978-3-662-47398-6_128 ↗
5. 10.1042/bj2008063210.1042/bj20080632 ↗
6. 10.3390/cells1108131210.3390/cells11081312 ↗
7. 10.1016/s0008-6363(97)00233-210.1016/s0008-6363(97)00233-2 ↗
8. 10.1016/S0021-9258(18)42138-210.1016/S0021-9258(18)42138-2 ↗
9. 10.3390/ijms2110361310.3390/ijms21103613 ↗
10. 10.1146/annurev-med-041316-08521510.1146/annurev-med-041316-085215 ↗
11. 10.1007/s00109-005-0688-710.1007/s00109-005-0688-7 ↗
12. 10.1016/j.semcancer.2017.07.00110.1016/j.semcancer.2017.07.001 ↗
13. 10.1146/annurev.immunol.021908.13260310.1146/annurev.immunol.021908.132603 ↗
14. 10.1016/j.jep.2021.11399110.1016/j.jep.2021.113991 ↗
15. 10.1016/j.jep.2013.09.02710.1016/j.jep.2013.09.027 ↗
16. 10.3390/antiox909082410.3390/antiox9090824 ↗
17. 10.1016/j.phymed.2013.01.00110.1016/j.phymed.2013.01.001 ↗
18. 10.1038/s41392-020-00447-610.1038/s41392-020-00447-6 ↗
19. 10.1016/j.biopha.2018.05.07210.1016/j.biopha.2018.05.072 ↗
20. 10.1016/j.ejphar.2022.17517610.1016/j.ejphar.2022.175176 ↗
21. 10.3390/nu1010156210.3390/nu10101562 ↗
22. 10.1007/s11418-014-0837-910.1007/s11418-014-0837-9 ↗
23. 10.1002/anie.20180578110.1002/anie.201805781 ↗
24. 10.1002/adma.20200735610.1002/adma.202007356 ↗
25. 10.1021/acsnano.9b0552110.1021/acsnano.9b05521 ↗
26. 10.1016/j.ejphar.2016.06.00610.1016/j.ejphar.2016.06.006 ↗
27. 10.1016/j.arr.2020.10103610.1016/j.arr.2020.101036 ↗
28. 10.1111/acel.1208910.1111/acel.12089 ↗
29. 10.1155/2020/714565610.1155/2020/7145656 ↗
30. 10.1038/sj.jid.570034010.1038/sj.jid.5700340 ↗
31. 10.1021/acs.jafc.0c0805210.1021/acs.jafc.0c08052 ↗
32. 10.1016/j.ejmech.2015.04.04010.1016/j.ejmech.2015.04.040 ↗
33. 10.1089/ars.2009.307410.1089/ars.2009.3074 ↗
34. 10.1038/nrn221410.1038/nrn2214 ↗
35. Calabrese V. · Ital J. Biochem · 2006 · 55 · 263
36. 10.1590/s0037-8682198900040000710.1590/s0037-86821989000400007 ↗
37. 10.1016/s0378-8741(01)00391-910.1016/s0378-8741(01)00391-9 ↗
38. 10.1155/2017/685146410.1155/2017/6851464 ↗
39. 10.1055/s-2006-95935910.1055/s-2006-959359 ↗
40. 10.1021/acsnano.8b0145610.1021/acsnano.8b01456 ↗
41. 10.1002/anie.20131113610.1002/anie.201311136 ↗
42. 10.1016/j.phrs.2020.10474410.1016/j.phrs.2020.104744 ↗
43. 10.1007/s12011-021-02773-410.1007/s12011-021-02773-4 ↗
44. 10.1016/j.envres.2022.11447510.1016/j.envres.2022.114475 ↗
45. 10.1038/sj.jid.570026010.1038/sj.jid.5700260 ↗
46. 10.7150/thno.2971510.7150/thno.29715 ↗
47. 10.1016/j.biomaterials.2015.08.03410.1016/j.biomaterials.2015.08.034 ↗
48. 10.1080/1061186080247246110.1080/10611860802472461 ↗
49. 10.1186/s12951-022-01657-610.1186/s12951-022-01657-6 ↗
50. 10.1002/adma.20210847610.1002/adma.202108476 ↗
51. 10.1002/med.2163710.1002/med.21637 ↗
52. 10.1038/s12276-020-00506-610.1038/s12276-020-00506-6 ↗